Hanall Biopharma Co (XKRX:009420) Days Sales Outstanding : 44.63 (As of Dec. 2023)

View and export this data going back to 1989. Start your Free Trial

What is Hanall Biopharma Co Days Sales Outstanding?

Hanall Biopharma Co's average Accounts Receivable for the three months ended in Dec. 2023 was ₩15,512 Mil. Hanall Biopharma Co's Revenue for the three months ended in Dec. 2023 was ₩31,718 Mil. Hence, Hanall Biopharma Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 44.63.

The historical rank and industry rank for Hanall Biopharma Co's Days Sales Outstanding or its related term are showing as below:

XKRX:009420' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.47 Med: 63.93 Max: 115.71
Current: 54.49

During the past 13 years, Hanall Biopharma Co's highest Days Sales Outstanding was 115.71. The lowest was 38.47. And the median was 63.93.

XKRX:009420's Days Sales Outstanding is ranked better than
67.43% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 71.68 vs XKRX:009420: 54.49

Hanall Biopharma Co's Days Sales Outstanding declined from Dec. 2022 (59.68) to Dec. 2023 (44.63).

Hanall Biopharma Co Days Sales Outstanding Historical Data

The historical data trend for Hanall Biopharma Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanall Biopharma Co Days Sales Outstanding Chart

Hanall Biopharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

52.92

56.18

38.47

60.64

57.25

Hanall Biopharma Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															59.68	63.60	47.35	62.16	44.63

Competitive Comparison of Hanall Biopharma Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Hanall Biopharma Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hanall Biopharma Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hanall Biopharma Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Hanall Biopharma Co's Days Sales Outstanding falls into.

Hanall Biopharma Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Hanall Biopharma Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (26688.865	+	15630.329)	/	2 )	/	134909.838	*	365
=	21159.597					/	134909.838	*	365
=	57.25

Hanall Biopharma Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (15393.264	+	15630.329)	/	2 )	/	31718.153	*	365 / 4
=	15511.7965					/	31718.153	*	365 / 4
=	44.63

Hanall Biopharma Co (XKRX:009420) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Hanall Biopharma Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Hanall Biopharma Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Hanall Biopharma Co (XKRX:009420) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanall Biopharma Co Ltd (XKRX:009420) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

12 Bongeunsa-ro 114-gil, Daewoong Building, 3rd Floor, Gangnam-gu, Seoul, KOR

Website

http://www.hanall.co.kr

Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Hanall Biopharma Co (XKRX:009420) Headlines

No Headlines